NYSE · CIK 0001140859 · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
CENCORA, INC.
COR chart by TradingView
PRICE HISTORY
LIVE · NYSECOR chart by TradingView
- REVENUE FY2025 ENDED SEP 2025
- $321B
- EBITDA
- $3.7B
- FREE CASH FLOW
- $3.2B
- EPS
- $7.96
- GROSS MARGIN
- 3.57%
- ROIC
- 32.29%
Q3 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
20.9x
+64%11.6x50.4x
⤢
P / SALES (TTM)
0.2x
+33%0.1x0.2x
⤢
P / BOOK
18.0x
+111%5.1x630.1x
⤢
EV / EBITDA (TTM)
15.6x
+51%7.9x19.4x
⤢
EV / REVENUE (TTM)
0.2x
+44%0.1x0.2x
⤢
FCF YIELD (TTM)
7.40%
-7.5pp-1.46%14.94%
⤢
DIVIDEND YIELD (TTM)
0.83%
-0.5pp0.67%1.36%
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$84.8B
+126%⤢
EBITDA (DERIVED)
$1.4B
+229%⤢
NET INCOME
$0.8B
+424%⤢
EPS (DILUTED)
$3.94
+507%⤢
REVENUE GROWTH YOY
5.07%
-0.8pp0.28%19.63%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
2.86%
-0.3pp-3.47%4.27%
⤢
RETURN ON CAPITAL
21.95%
-18.0pp-90.61%213.25%
⤢
RETURN ON EQUITY (TTM)
86.03%
+19.0pp-9862.07%821.13%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN4.26%
OPERATING MARGIN1.32%
NET MARGIN0.90%
FCF MARGIN2.86%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$2.4B
+102%⤢
STOCK-BASED COMP
$0.0B
+241%⤢
CAPITAL EXPENDITURE
$0.2B
+46%⤢
SHARES OUTSTANDING
0.19B
-14%⤢
DIVIDEND / SHARE
$0.60
+64%BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$2.8B
+3%⤢
TOTAL DEBT
$11.7B
+180%⤢
DEBT / EBITDA (TTM)
2.9x
+30%1.3x3.2x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 100.02%INSIDERS 4.31%OTHER / RETAIL 0.00%1,886 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 10.25% | 19.9M | $6.39B | -1.7% |
| Vanguard Capital Management LLC | 6.33% | 12.3M | $3.95B | NEW |
| Vanguard Portfolio Management LLC | 4.93% | 9.6M | $3.07B | NEW |
| State Street Corporation | 4.72% | 9.2M | $2.95B | -1.2% |
| Price (T.Rowe) Associates Inc | 3.76% | 7.3M | $2.35B | +4.7% |
| FMR, LLC | 3.44% | 6.7M | $2.14B | +22.5% |
| T. Rowe Price Investment Management, Inc. | 3.24% | 6.3M | $2.02B | -6.1% |
| Geode Capital Management, LLC | 2.86% | 5.6M | $1.78B | +1.9% |
| JPMORGAN CHASE & CO | 2.51% | 4.9M | $1.57B | -1.9% |
| Boston Partners | 2.50% | 4.9M | $1.56B | +8.6% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.